Investigating Novel Interventions for Low Back Pain in US Military Veterans: A Randomized Controlled Adaptive Phase II Trial

NCT ID
NCT05935761
Registry status
Not yet recruiting
Study type
Not specified in the registry data
Phase
Phase 2
Sponsor
VA Office of Research and Development

Overview

ClinicalTrials.gov lists this study as Not yet recruiting.

Enrollment: 108 participants (Estimated).

What is being studied

No interventions are listed in the registry data.

Who may be eligible

Ages
Not specified in the registry data
Sex
Not specified in the registry data
Healthy volunteers accepted
No

ClinicalTrials.gov lists the following eligibility criteria.

Inclusion Criteria: * Veterans with chronic low back pain * Based on medical history and medical records, have low back pain (Thoracic Vertebrae 6 or below) present on most days for the preceding 6 months or longer, and fulfill all disease diagnostic criteria (please see disease diagnostic criteria below) * Have a weekly mean of 24-hour average pain score 4 at baseline * Negative pregnancy test if female. Sexually active subjects are required to use a medically acceptable form of birth control if they are of childbearing potential and could become pregnant during the study. A medically acceptable form of birth control includes non-hormonal intrauterine devices, surgical sterilization, or double barrier methods (e.g. diaphragm with contraceptive jelly, condom with contraceptive foam, cervical caps with contraceptive jelly). Sexual abstinence with agreement to continue abstinence or to use a medically acceptable method of contraception (as listed above) should sexual activity occur is permissible * No change in medications less than 4 weeks before baseline * No anticipated need to alter psychotropic or pain medications for the 6-wk study duration (as determined by study physician's review of records and/or discussion with prescribing physician) * Ability to fully participate in the informed consent process Exclusion Criteria: * Unstable medical or neurological illness, including seizures, renal impairment or cerebral vascular accident (CVA) * Use of oral contraceptives or other hormonal supplements-this is out of caution, as it is unknown if the study medications would impact the efficacy of hormonal contraception * Significant suicidal or homicidal ideation that necessitates intervention * Daily use of long or short-acting narcotic medications (PRN use will be considered) * Current DSM-5 diagnosis of bipolar disorder, schizophrenia, or other psychotic disorder, or cognitive disorder due to a general medical condition * Female participants who are pregnant or breast-feeding * Known allergy to study medication * History of moderate or severe TBI (mild TBI is permissible) * DSM-5 criteria met for alcohol and/or other substance abuse or dependence within past three months (excludes caffeine and nicotine) * Have received epidural steroids, facet block, nerve block or other invasive procedures aimed to reduce low back pain within the past 3 months prior to Visit 1 * Have ongoing or anticipated disability compensation or litigation issues, in the best judgment of the investigator * Have a presence of any factors/conditions, medical or other, that in the judgment of the investigator may interfere with performance of study outcome measures, such as treatment-refractory history * Have serious or unstable cardiovascular, hepatic, renal, metabolic, respiratory, or hematologic illness, symptomatic peripheral vascular disease, or other medical condition or psychiatric conditions that, in the opinion of investigator and study physician, would compromise participation or be likely to lead to hospitalization during the study

Study locations

1 study location is listed.

Site recruitment status is not specified in the registry data for these locations.

Countries: United States

  • North Carolina, United States: 1

Sample of listed locations

  • Durham VA Medical Center, Durham, NC — Durham, North Carolina, 27705-3875, United States — Site recruitment status not specified in the registry data

Study details

Start date
December 1, 2026
Primary completion date
October 1, 2029
First posted
July 7, 2023

Source and update information

Source
ClinicalTrials.gov
NCT ID
NCT05935761
Registry last updated
September 8, 2026
QualifiedStudies registry data refreshed
September 21, 2026

View NCT05935761 on ClinicalTrials.gov

Trial information can change. Confirm current study details with the study team or the registry.

About joining clinical research

Find clinical trials you may match with

QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.

Find clinical trials you may match with | Low Back Pain studies | Clinical trial FAQ